A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials

E-ISSN： 1873-5592|11|5|536-545

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.5, 2010-05, pp. : 536-545

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Osteoarthritis IV: Clinical therapeutic trials and treatment

By Buchanan W. W. Kean W. F.

Inflammopharmacology, Vol. 10, Iss. 1-2, 2002-02 ,pp. : 79-155

VSP

Access to resources Recommend Favorite

Stratification and Partial Ascertainment of Biomarker Value in Biomarker-Driven Clinical Trials

Journal of Biopharmaceutical Statistics, Vol. 24, Iss. 5, 2014-09 ,pp. : 1011-1021

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical Trials Simulation: A Statistical Approach

By Westfall Peter

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 611-630

Taylor & Francis Ltd

Access to resources Recommend Favorite

Validation Testing in Thorough QT/QTc Clinical Trials

By Tsong Yi Zhong Jinglin Chen Wen Jen

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 3, 2008-05 ,pp. : 529-541

Taylor & Francis Ltd

Access to resources Recommend Favorite

Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 4, 2011-12 ,pp. : 286-298

Bentham Science Publishers

Access to resources Recommend Favorite